Amicus Therapeutics
FOLD
#3917
Rank
HK$23.64 B
Marketcap
HK$76.63
Share price
-0.51%
Change (1 day)
0.21%
Change (1 year)

Amicus Therapeutics (FOLD) - Cash on Hand

Cash on Hand as of September 2025 : HK$2.05 Billion

According to Amicus Therapeutics 's latest financial reports the company has HK$2.05 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Amicus Therapeutics - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$1.94 B-13.19%
2023-12-31HK$2.23 B-2.56%
2022-12-31HK$2.29 B-39.03%
2021-12-31HK$3.76 B0.42%
2020-12-31HK$3.74 B6.25%
2019-12-31HK$3.52 B-10.69%
2018-12-31HK$3.94 B40.93%
2017-12-31HK$2.80 B9.36%
2016-12-31HK$2.56 B54.42%
2015-12-31HK$1.65 B41.01%
2014-12-31HK$1.17 B85.02%
2013-12-31HK$0.63 B-17.24%
2012-12-31HK$0.76 B77.59%
2011-12-31HK$0.43 B-48.26%
2010-12-31HK$0.83 B37.86%
2009-12-31HK$0.60 B-35.2%
2008-12-31HK$0.93 B-25.68%
2007-12-31HK$1.25 B196.04%
2006-12-31HK$0.42 B124.71%
2005-12-31HK$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Biogen
BIIB
HK$30.81 B 1,401.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$11.49 B 460.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$0.71 B-64.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.57 B 1,584.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
HK$0.90 B-56.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$39.86 B 1,841.87%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark